IOVENE, Maria Rosaria
 Distribuzione geografica
Continente #
NA - Nord America 1.154
EU - Europa 1.102
AS - Asia 163
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.423
Nazione #
US - Stati Uniti d'America 1.152
IE - Irlanda 380
UA - Ucraina 193
GB - Regno Unito 145
IT - Italia 136
DE - Germania 95
CN - Cina 79
SG - Singapore 49
FI - Finlandia 46
GR - Grecia 37
SE - Svezia 31
TR - Turchia 31
FR - Francia 19
BE - Belgio 11
ES - Italia 4
CA - Canada 2
CH - Svizzera 2
EU - Europa 2
BR - Brasile 1
EC - Ecuador 1
HR - Croazia 1
IR - Iran 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 2.423
Città #
Dublin 380
Jacksonville 292
Chandler 237
Ann Arbor 58
New York 58
Princeton 56
Medford 52
San Mateo 31
Boardman 30
Wilmington 30
Naples 27
Roxbury 23
Singapore 23
Woodbridge 23
Jinan 13
Beijing 12
Bremen 12
Cambridge 11
Brussels 10
Mountain View 9
Nanjing 9
Caserta 8
Des Moines 8
Napoli 8
Norwalk 8
Auburn Hills 6
Selargius 6
Düsseldorf 5
Falls Church 5
Milan 5
Lanzhou 4
Houston 3
Nanchang 3
Teramo 3
Burgdorf 2
Caivano 2
Guangzhou 2
Hebei 2
La Spezia 2
Ningbo 2
Portici 2
Redwood City 2
Rivergaro 2
Rome 2
Talavera de la Reina 2
Zhengzhou 2
Ajax 1
Avella 1
Brescia 1
Cagliari 1
Casalnuovo Di Napoli 1
Changsha 1
Chicago 1
Dallas 1
Dearborn 1
Fairfield 1
Florence 1
Fuzhou 1
Haikou 1
Hangzhou 1
Hefei 1
Ho Chi Minh City 1
Jiaxing 1
Kunming 1
Lincoln 1
Liège 1
London 1
Los Angeles 1
Madrid 1
Makati City 1
Montréal 1
Munich 1
Nürnberg 1
Pesaro 1
Prato 1
Quito 1
Rawang 1
Redmond 1
Sestri Levante 1
Stockholm 1
Tabriz 1
Taizhou 1
Tarzana 1
Teano 1
Tianjin 1
Tito 1
Torino 1
Uppsala 1
Uzzano 1
Venice 1
Vertova 1
Zagreb 1
Totale 1.538
Nome #
Lactobacillus crispatus modula l’espressione di TLR-2/4, la produzione di IL-8 e di β-defensine 2/3 di cellule epiteliali HeLa in vitro 85
Antimicrobial effect of natural polyphenols with or without antibiotics on Chlamydia pneumoniae infection in vitro. 67
Intestinal Dysbiosis and Yeast Isolation in stool of subjects with Autism Spectrum Disorders 64
Antimicrobial action of Nitens mouthwash (cetyltrimethylammonium naproxenate) on multiple isolates of pharyngeal microbes: a controlled study against chlorhexidine, benzydamine, hexetidine, amoxicillin, amoxicillin-clavulanate, clarithromycin, and cefaclor 63
Clinical and pharmacokinetic study of cefotetan in biliary tract infections: preliminary report 60
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 59
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 58
Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. 57
[Validity and limitations of antibiotic prevention in surgery. Multicenter clinical study] 57
[Activity of serum monoamine oxidase (SMAO) in patients with connective tissue diseases : preliminary results] 55
Aztreonam in the therapy of nosocomial infections in patients with impaired host defenses 54
A new enrichment diagnostic platform for semen culture 54
First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review 54
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori 53
Cefoperazone therapy of bacterial meningitis: a clinical trial 53
Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide. 53
Hyperproduction of fibrin and inefficacy of antithrombin III and alpha2 macroglobulin in the presence of bacterial porins. 51
Microbial Evaluation in Capsular Contracture of Breast Implants 51
Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children. 50
[Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract] 49
Clinical evaluation of imipenemcilastatin in the therapy of severe infections in high risk patients. 49
Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury 47
Clinical evaluation of the imipenem/cilastatin combination in the therapy of severe infections in patients with malignant diseases 47
Central serous chorioretinopathy and Helicobacter pylori 46
Cefotaxime (HR-756) in urinary tract infections 46
Aumentata induzione di MM-9 e VEGF in cellule endoteliali umane infettate con Chlamydia pneumoniae 46
[Evaluation of monoamine oxidase in the serum (SMAO) of clinically healthy volunteers] 45
THE IN VITRO EFFECTS OF CETYLTRIMETHYLAMMONIUM NAPROXENATE ON ORAL AND PHARYNGEAL MICROORGANISMS OF VARIOUS ECOLOGICAL NICHES 44
Antibiotic therapy in biliary tract infections: clinical experiences with mezlocillin 43
Clinical experience with ofloxacin (DL-8280) in the therapy of various infections 43
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 42
Cefamandole concentrations in the anterior chamber of the eye in rabbits and humans 42
[Clinical study of the efficacy and tolerability of a combination netilmicin and cefotaxime in the treatment of severe infections] 42
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 42
Assessment of bacterial infection in chronic wounds in the elderly: biopsy versus VERSAJET. 41
Effect of moxifioxacin and human beta-defensin 2 on ICAM-1 and cytokines expression in human lung epithelial cell line 41
Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients 39
Clinical experience with pefloxacin in the therapy of typhoid fever 39
Methicillin-resistant Staphylococcus aureus: epidemiology and antimicrobial susceptibility experiences from the University Hospital ‘Luigi Vanvitelli’ of Naples 39
Campylobacter jejuni bacteremia in Italian pediatric patients with acute lymphoblastic leukemia: Report of two cases 38
Sporotrichoid Cutaneous Infection by Mycobacterium Abscessus: a Case Report 37
Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance 35
Prevalence of anti-microbial resistance in eighty clinical isolates of Helicobacter pylori 35
Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae. 32
Marine antimicrobial peptides: Nature provides templates for the design of novel compounds against pathogenic bacteria 32
Failure of first line eradication treatment significantly increases prevalence of anti-microbial resistant helicobacter pylori clinical isolates 31
Non-dermatophytic onychomycosis diagnostic criteria: an unresolved question 31
Enrichment of semen culture in the diagnosis of bacterial prostatitis 31
Optimized non-bismuth quadruple therapies cure most patients infected with Helicobacter pylori despite resistance to Clarithromycin and Metronidazole 30
Pefloxacin versus chloramphenicol in the therapy of typhoid fever 29
Pretreatment antimicrobial-susceptibility testing in the eradication of Helicobacter pylori infection 28
Prevalence and antimicrobial susceptibility patterns of bacterial pathogens in urinary tract infections in university hospital of campania “luigi vanvitelli” between 2017 and 2018 28
Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection 26
Distribution of Hepatitis C Virus Genotypes and Subtypes in the Metropolitan Area of Naples, Italy, in the Era of Interferon-Free Regimens. 25
Sporotrichosis: success of itraconazole treatment 24
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis 16
Totale 2.478
Categoria #
all - tutte 10.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020308 58 55 8 5 52 9 61 11 30 10 7 2
2020/2021413 42 0 53 15 83 4 58 51 0 57 44 6
2021/2022322 36 1 0 11 115 5 14 12 17 9 15 87
2022/2023787 71 19 41 74 66 68 0 49 366 7 14 12
2023/2024276 22 2 10 20 86 61 4 0 0 3 12 56
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 2.478